Abstract | OBJECTIVE: DESIGN: We performed detailed clinical and laboratory assessments of this family to characterize the effects of CaSR mutation on several endocrine organs expressing CaSR. RESULTS: Interestingly, we could not detect any failure in the function of any tissues we examined, except in serum calcium levels. CONCLUSIONS: To our knowledge, this has been the first report from Eastern and Central Europe showing P55 L mutation of the CaSR, as well as the first publication discussing the effect of this mutation on several endocrine systems containing CASR.
|
Authors | G Speer, M Tóth, H-H Niller, D Salamon, I Takács, P Miheller, A Patócs, Z Nagy, E Bajnok, P Nyiri, P Lakatos |
Journal | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
(Exp Clin Endocrinol Diabetes)
Vol. 111
Issue 8
Pg. 486-90
(Dec 2003)
ISSN: 0947-7349 [Print] Germany |
PMID | 14714270
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Codon
- Receptors, Calcium-Sensing
- Calcium
|
Topics |
- Adult
- Base Sequence
- Bone Density
- Calcium
(metabolism, urine)
- Codon
- Endocrine Glands
(physiopathology)
- Female
- Genes, Dominant
- Heterozygote
- Humans
- Hypercalcemia
(genetics, metabolism, physiopathology, urine)
- Male
- Middle Aged
- Mutation
- Receptors, Calcium-Sensing
(genetics)
|